Healthways Inc. (NASDAQ:HWAY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Tuesday.

According to Zacks, “We believe that Healthways has a substantial pipeline of potential contracts with new and existing customers in both domestic and international markets, which should drive growth. The recently completed organizational restructure is expected to generate cost savings from full-year 2017, which will boost profitability. Meanwhile, estimates have been going up after posting stable second-quarterly results. We note that the company has positive record of earnings surprises in recent quarters. However, declining revenues are a concern. Significant competition in population health management solutions market also remains a major concern.”

Several other analysts have also recently issued reports on HWAY. Oppenheimer Holdings Inc. raised Healthways to an “outperform” rating and set a $27.00 price objective on the stock in a report on Sunday, August 14th. FBR & Co upped their price objective on Healthways from $16.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, August 10th. Jefferies Group upped their price objective on Healthways from $13.00 to $18.50 and gave the stock a “hold” rating in a report on Thursday, August 4th. Barclays PLC raised Healthways from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $12.00 to $27.00 in a report on Monday, August 22nd. Finally, Piper Jaffray Cos. upped their price objective on Healthways from $15.00 to $25.50 and gave the stock an “overweight” rating in a report on Wednesday, August 10th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Healthways has an average rating of “Buy” and an average price target of $22.93.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/healthways-inc-hway-lowered-to-hold-at-zacks-investment-research.html

Shares of Healthways (NASDAQ:HWAY) traded down 1.179% during mid-day trading on Tuesday, reaching $25.565. The company had a trading volume of 957,901 shares. The firm has a 50-day moving average price of $23.14 and a 200-day moving average price of $14.54. Healthways has a 1-year low of $9.18 and a 1-year high of $27.30. The stock’s market capitalization is $939.21 million.

Healthways (NASDAQ:HWAY) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.53. Healthways had a positive return on equity of 8.83% and a negative net margin of 31.32%. The company had revenue of $125 million for the quarter, compared to analysts’ expectations of $186.88 million. During the same period in the previous year, the firm earned $0.11 EPS. The firm’s revenue was up 10.2% compared to the same quarter last year. Equities analysts expect that Healthways will post $2.11 earnings per share for the current year.

In other news, Director Mary Jane England sold 3,816 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $24.78, for a total transaction of $94,560.48. Following the transaction, the director now owns 39,068 shares of the company’s stock, valued at approximately $968,105.04. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 14.01% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the stock. State Board of Administration of Florida Retirement System increased its position in shares of Healthways by 0.4% in the second quarter. State Board of Administration of Florida Retirement System now owns 34,156 shares of the company’s stock valued at $395,000 after buying an additional 130 shares during the period. Arizona State Retirement System increased its position in shares of Healthways by 1.2% in the second quarter. Arizona State Retirement System now owns 16,283 shares of the company’s stock valued at $188,000 after buying an additional 200 shares during the period. Profund Advisors LLC increased its position in shares of Healthways by 4.5% in the second quarter. Profund Advisors LLC now owns 10,668 shares of the company’s stock valued at $123,000 after buying an additional 456 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in shares of Healthways by 7.6% in the second quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 11,685 shares of the company’s stock valued at $135,000 after buying an additional 825 shares during the period. Finally, Nationwide Fund Advisors increased its position in shares of Healthways by 1.2% in the second quarter. Nationwide Fund Advisors now owns 70,840 shares of the company’s stock valued at $818,000 after buying an additional 851 shares during the period. 92.52% of the stock is currently owned by hedge funds and other institutional investors.

About Healthways

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

5 Day Chart for NASDAQ:HWAY

Get a free copy of the Zacks research report on Healthways (HWAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Healthways Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthways Inc. and related companies with MarketBeat.com's FREE daily email newsletter.